Biotech · Private company · Rochester, MN, US
Vyriad, Inc.
Track this companyFree. Adds Vyriad, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials73 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- CemiplimabPhase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- ipilimumab + nivolumabPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- VSV-IFNβ-NISPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- VV1Phase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- AtezolizumabPhase 1 · Recurrent Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- MV-NISPhase 1 · Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- MV-NISPhase 1 · Recurrent Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- VSV-IFNβ-NISPhase 1 · Malignant Solid TumourClinicalTrials.gov · fetched Nov 12, 2026
- VSV-IFNβ-NIS and avelumabPhase 1 · Malignant Solid TumourClinicalTrials.gov · fetched Nov 12, 2026
- VV169Phase 1 · Multiple Myeloma RefractoryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Phase 1 Dose-escalation and Expansion Study of In Vivo BCMA-CAR T Cell Therapy (VV169) in Patients With Relapsed or Refractory Multiple MyelomaPHASE1 · RECRUITING · started Sep 8, 2026ClinicalTrials.gov NCT07802717 · fetched Nov 12, 2026
- Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsPHASE2 · ACTIVE_NOT_RECRUITING · started Apr 24, 2020ClinicalTrials.gov NCT04291105 · fetched Nov 12, 2026
- Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid TumorsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Apr 9, 2019ClinicalTrials.gov NCT03647163 · fetched Nov 12, 2026
- Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical CystectomyPHASE1 · COMPLETED · started Jul 20, 2018ClinicalTrials.gov NCT03171493 · fetched Nov 12, 2026
- Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With AtezolizumabPHASE1 · TERMINATED · started Aug 3, 2017ClinicalTrials.gov NCT02919449 · fetched Nov 12, 2026
- Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid TumorsPHASE1 · COMPLETED · started Apr 17, 2017ClinicalTrials.gov NCT02923466 · fetched Nov 12, 2026
- Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRTPHASE1 · COMPLETED · started Feb 22, 2017ClinicalTrials.gov NCT02962167 · fetched Nov 12, 2026
NIH awards1
- Off-the-shelf in vivo CAR-T therapy for multiple myelomaFiscal year 2026 · $1MNIH RePORTER 1R44CA314911-01 · fetched Nov 12, 2026